{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:52:22Z","timestamp":1778917942135,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Conacyt Mexico","award":["129889"],"award-info":[{"award-number":["129889"]}]},{"name":"IPN Mexico","award":["20140229"],"award-info":[{"award-number":["20140229"]}]},{"name":"NIH","award":["HL-43617"],"award-info":[{"award-number":["HL-43617"]}]},{"name":"NIH","award":["AT004277"],"award-info":[{"award-number":["AT004277"]}]},{"name":"NIH","award":["DK 092154"],"award-info":[{"award-number":["DK 092154"]}]},{"name":"Conacyt Fellowship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejphar.2014.09.042","type":"journal-article","created":{"date-parts":[[2014,10,3]],"date-time":"2014-10-03T19:25:08Z","timestamp":1412364308000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling"],"prefix":"10.1016","volume":"744","author":[{"given":"Pilar","family":"Ortiz-Vilchis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina Go","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Rubio-Gayosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Ramirez-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Calzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Romero-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Meaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pam","family":"Taub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2155-3934","authenticated-orcid":false,"given":"Guillermo","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.09.042_bib1","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1742-4658.2006.05213.x","article-title":"The mitochondrial permeability transition from in vitro artifact to disease target","volume":"273","author":"Bernardi","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2014.09.042_bib2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/eurheartj\/ehq068","article-title":"Chocolate consumption in relation to blood pressure and risk of cardiovascular disease in German adults","volume":"31","author":"Buijsse","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2014.09.042_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2011.05.005","article-title":"Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases","volume":"64","author":"Castro","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2014.09.042_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.niox.2012.01.009","article-title":"Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability","volume":"26","author":"Castro","year":"2012","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejphar.2014.09.042_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/eurheartj\/eht420","article-title":"Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial","volume":"35","author":"Cerisiano","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2014.09.042_bib6","doi-asserted-by":"crossref","first-page":"e95913","DOI":"10.1371\/journal.pone.0095913","article-title":"Rat experimental model of myocardial ischemia\/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain","volume":"9","author":"Ciuffreda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.09.042_bib7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.827022","article-title":"Cocoa and cardiovascular health","volume":"119","author":"Corti","year":"2009","journal-title":"Circulation"},{"issue":"287\u2013303","key":"10.1016\/j.ejphar.2014.09.042_bib8","article-title":"Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties","volume":"37","author":"Galati","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2014.09.042_bib9","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/1755-5922.12010","article-title":"The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction","volume":"31","author":"Ghaffari","year":"2013","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2014.09.042_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3949\/ccjm.61.4.308","article-title":"Cyclosporine: mechanisms of action and toxicity","volume":"61","author":"Graham","year":"1994","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.ejphar.2014.09.042_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1196\/annals.1341.022","article-title":"Mitochondria and ischemia\/reperfusion injury","volume":"1047","author":"Honda","year":"2005","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ejphar.2014.09.042_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2796.2009.02088.x","article-title":"Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program","volume":"266","author":"Janszky","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2014.09.042_bib13","article-title":"Vascular action of cocoa flavanols in humans: the roots of the story","volume":"2","author":"K Hollenberg","year":"2006","journal-title":"J. Cardiovasc Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.042_bib14","doi-asserted-by":"crossref","first-page":"e001644","DOI":"10.1161\/JAHA.112.001644","article-title":"Reduction of ischemia\/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide","volume":"1","author":"Kloner","year":"2012","journal-title":"J. Am Heart Assoc."},{"key":"10.1016\/j.ejphar.2014.09.042_bib15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(01)01550-9","article-title":"ST segment resolution as a tool for assessing the efficacy of reperfusion theraphy","volume":"38","author":"Lemos","year":"2001","journal-title":"J. Am Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2014.09.042_bib16","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1582-4934.2010.01235.x","article-title":"Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure","volume":"15","author":"Lim","year":"2011","journal-title":"J. Cell Mol. Med."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2014.09.042_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvu082.90","article-title":"Cardioprotection by pharmacological agents targeting mitochondria is preserved in isolated aged rat hearts","volume":"15","author":"Muntean","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2014.09.042_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJMoa071142","article-title":"Effect of cyclosporine on reperfusion injury in acute myocardial infarction","volume":"359","author":"Piot","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2014.09.042_bib19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jacc.2008.06.028","article-title":"Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection","volume":"52","author":"Romero-Perez","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2014.09.042_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2003.09.050","article-title":"Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to Smac\/DIABLO, and reduces the mitochondrial leakage of cytochrome C and Smac\/DIABLO","volume":"43","author":"Scarabelli","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2014.09.042_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.taap.2013.08.027","article-title":"Minocycline and doxycycline, but not other tetracycline-derived compounds, protect liver cells from chemical hypoxia and ischemia\/reperfusion injury by inhibition of the mitochondrial calcium uniporter","volume":"273","author":"Schwartz","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"Pt 2","key":"10.1016\/j.ejphar.2014.09.042_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/BJ20042006","article-title":"Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion","volume":"390","author":"Solaini","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2014.09.042_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.fct.2012.12.010","article-title":"(-) Epicatechin attenuates mitochondrial damage by enhancing mitochondrial multi-marker enzymes, adenosine triphosphate and lowering calcium in isoproterenol induced myocardial infarcted rats","volume":"53","author":"Stanely Mainzen Prince","year":"2013","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.ejphar.2014.09.042_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.09.042_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pharmthera.2006.08.002","article-title":"Interactions between drugs and occupied receptors","volume":"113","author":"Tallarida","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2014.09.042_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000089090.05757.34","article-title":"Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling","volume":"108","author":"Villarreal","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2014.09.042_bib27","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u05f3s disease","volume":"100","author":"Wang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejphar.2014.09.042_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijcard.2014.05.009","article-title":"Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function","volume":"175","author":"Yamazaki","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2014.09.042_bib29","doi-asserted-by":"crossref","first-page":"H761","DOI":"10.1152\/ajpheart.00413.2008","article-title":"Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury","volume":"295","author":"Yamazaki","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2014.09.042_bib30","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.jacc.2010.01.055","article-title":"Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion","volume":"55","author":"Yamazaki","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2014.09.042_bib31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2014.09.042_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cardiores.2006.02.025","article-title":"The role of oxidants and free radicals in reperfusion injury","volume":"70","author":"Zweier","year":"2006","journal-title":"Cardiovasc. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T16:58:20Z","timestamp":1565888300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914006980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":32,"alternative-id":["S0014299914006980"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.042","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}